Furthermore, positive Oct-4 and Nanog expression in breast cancer was not associated with patient age or clinical stage of the tumor, but was significantly associated with tumor size, histological grade, lymph node status, and molecular subtype. This evidence concerns the gene NANOG and breast carcinoma.